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Abstract
Background The prevalence of coronary heart disease amongst South Asian population in the UK is higher compared to the 
general population. Objective This study sought to investigate beliefs and experiences of South Asian patients regarding 
coronary heart disease and medication taking behaviour. Setting A London Heart Attack Centre. Methods This mixed method 
study is part of an original pilot randomised study on 71 patients involving a pharmacy-led intervention to improve medication 
adherence in coronary heart disease patients. South Asian patients from the randomised study took part in qualitative semi-
structured telephone interviews. Both South Asian and non-South Asian patients completed the questionnaire about adherence 
and beliefs regarding medicines using Morisky Scale and the Belief About Medicines Questionnaire-Specific at 2 weeks, 3 
and 6 months. Outcome Patients’ beliefs about coronary heart disease and medication adherence. Results Seventeen South 
Asian patients and 54 non-South Asian patients took part. Qualitative data from 14 South Asian patients showed that while 
some attributed coronary heart disease to genetic, family history for their illness, others attributed it to their dietary patterns 
and ‘god’s will’ and that little could be done to prevent further episodes of coronary heart disease. On the Belief About 
Medicines Questionnaire-Specific in South Asian patients, beliefs about necessity of medicines outweighed concerns. South 
Asian patients (n = 17) showed a similar pattern of adherence compared to non-Asian patients (n = 54). Adherence decreased 
with time in both populations, adherence measured by Morisky Scale. Conclusion South Asian patients in this study often 
attributed coronary heart disease to additional causes besides the known risk factors. Future studies on their understanding 
of the importance of cultural context in their attitudes to prevention and lived experience of the disease is warranted.
Keywords Adherence · Cardiovascular medication · Coronary heart disease · South Asians · United Kingdom
Impacts on practice
• There is a need to promote both primary and secondary 
prevention interventions for adherence to medication in 
UK South Asian patients with coronary heart disease.
• There remains a need for education within the South 
Asian communities on the causes and prevention of coro-
nary heart disease.
Introduction
Coronary heart disease remains the most common cause of 
premature death in the UK. In 2014, 15% of male deaths 
and 10% of female deaths were from CHD, a total of around 
69,000 deaths [1]. South Asians (SAs) living in the UK (peo-
ple from India, Pakistan, Bangladesh, Sri Lanka and Nepal) 
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have a higher death rate from CHD at a younger age, often 
before the age of 40 years in men, 40% higher than the whole 
population [2]. It is important to mention that SAs are hetero-
geneous in relation to culture and risk factors for heart disease 
[3]. An explanation for excess deaths from CHD in SAs is still 
unclear. Several theories in previous literature include migra-
tion, disadvantaged socioeconomic status, proatherogenic 
diet, lack of exercise, high levels of homocysteine and LP(a) 
lipoprotein, endothelial dysfunction, enhanced plaque and 
systemic inflammation [4]. Other studies attribute this to the 
fact that SAs have substantially higher rates of diabetes, a risk 
factor often linked to higher CHD mortality [5]. People who 
have had a myocardial infarction (MI) benefit from treatment 
to reduce the risk of further manifestations of vascular disease; 
this is known as secondary prevention. Secondary prevention 
after an acute MI includes cardiac rehabilitation, lifestyle 
changes and drug therapy. The use of secondary prevention 
medication in patients after CHD is vital to maintain optimal 
heart function [6]. Research has shown that consistent use of 
medication after a coronary event is associated with lower 
adjusted mortality and higher survival rates [7, 8]. Cessation 
of secondary prevention medications can lead to rehospitali-
sation and re-infarction and increased risk of death [9, 10]. 
However, non-adherence rates to medication for MI patients 
range from 13 to 60% [9]. A systematic review of 17 studies 
[11] conducted in India, Pakistan and Sri Lanka investigated 
adherence rates to cardiovascular medication in SA patients. 
The review showed low rates for adherence of only 32% and 
concluded that there is a need for future interventions to target 
adherence in this vulnerable population, where premature car-
diovascular disease is a growing epidemic [11]. There has been 
little research on adherence to coronary heart disease medica-
tion in SA patients living in the UK, despite the relatively high 
prevalence of cardiovascular conditions in this group [6]. It 
is not clear if ethnicity plays a role in medication non adher-
ence [12], only few studies have been conducted [11, 12] and 
have shown that adherence to cardiovascular medication is low 
when compared to non-Asian counterparts [12].
There is a dearth of literature on how personal beliefs 
shape the way that medicines prescribed for the treatment of 
cardiovascular disease are taken by people of South Asian 
origin [13, 14]. There is hence a need to identify health 
beliefs that may contribute to health behaviours in South 
Asian patients with elevated risk of lifestyle-related disease 
[14]. Therefore, there is a need to look closer at this par-
ticular ethnic group regarding adherence and beliefs around 
medication after a CHD.
Aim of the study
To investigate the UK South Asian patients’ beliefs and 
lived early experiences about coronary heart diases and their 
beliefst, experiences and behaviours relating to medication 
taking in CHD.
Ethics approval
Ethics approval for the interviews was gained from National 
Research Ethics Service Committee North West –Preston, 
also from the R &D Joint Research Management Office 
Queen Mary Innovation Centre and the R&D office Univer-
sity College of London.
Methods
This was a mixed method study including qualitative in-
depth interviews followed by questionnaires. It was con-
ducted as part of an original pilot study [15] on 71 patients 
(54 non-Asians and 17 SAs) that assessed the impact of a 
pharmacy-led intervention to improve adherence amongst 
CHD patients. As an approach to focus on adherence to 
cardiac medication in only SA patients, 17 patients were 
invited to participate in a telephone interview, 3 months 
after hospital discharge.
Sampling and recruitment for the qualitative interviews: 
Eligibility criteria included 1-patients who have had a coro-
nary event unstable angina, ST elevation myocardial infarc-
tion or non ST elevation myocardial infarction, 2-were pre-
scribed secondary prevention medication, 3-were from SA 
origin, 4-could communicate in English and 5-had signed 
written consent to be part of the pilot study. These patients 
were approached before discharge by the researcher. This is 
to confirm if they would be interested in participating in tel-
ephone interviews. Seventeen patients matched the eligibil-
ity criteria and were invited to the interviews. Fourteen SA 
patients agreed. Ethnicity was determined from the patients’ 
hospital charts and further confirmed during the recruitment 
process.
Study setting
The study was undertaken in collaboration with a London 
Heart Attack Centre in a district in East London UK.
Data collection
Quantitative data on medication adherence: The self-report 
8-Item Morisky Medication Adherence Scale (MMAS-8) 
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was used to assess adherence [16]. The MMAS-8 has a high 
reliability, sensitivity and specificity and has been widely 
used in research on medication adherence. The MMAS-8was 
measured at baseline (2 weeks after discharge) and at 3 and 
6 months. The Belief about Medicines Questionnaire Spe-
cific (BMQ-S) was used to assess patients’ beliefs about 
their medication. It is a valid and reliable scale having been 
validated for use across a range of different diseases and 
also cardiac illnesses [17]. The BMQ specific is comprised 
of two subscales, which are BMQ necessity and BMQ con-
cerns. The BMQ specific was measured at 3 months.
Qualitative data: The questions were developed by the 
research team and adapted from previous literature [9]. Pre-
vious literature has shown that factors that influence med-
ication-taking behaviour in coronary heart disease include 
perception about both the disease and medicines [18].
Data processing and analysis
Data from the Morisky and BMQ-scale were analysed using 
SPSS Version 22 and linked with the results from the inter-
views. The BMQ specific scale is comprised of two sub-
scales, which are BMQ necessity and BMQ concerns. The 
scores of each subscale are computed from the sum of all 
items within that particular subscale and range from 5 to 
25. The necessity-concerns differential can be computed by 
subtracting the total BMQ concerns subscale score from the 
total BMQ necessity subscale score. A positive differential 
score indicates that the participants perceive the benefits of 
their medication to outweigh the risks, in contrast negative 
differential score indicates that participants perceive the risk 
of taking their medication outweigh their benefits. The dif-
ferential scores range from − 20 to 20 [17].
All interviews were transcribed verbatim. A framework 
approach to analysis was undertaken involving the devel-
opment of an initial coding framework with each domain 
of interview schedule, informed by literature and themes 
that emerged from the data. As analysis proceeded this was 
modified and refined using constant comparison techniques; 
in which all items of data assigned a particular code, were 
appraised for similarities and divergences from those already 
coded. To ensure reliability of the coding procedure, coding 
of the transcripts was undertaken by two members of the 
research team.
Results
A total of 71 patients took part in the study; 54 (76.0%) were 
males; 51 (71.8%) had experienced ST-elevation MI and 20 
(28.2%) non-ST elevation MI. Of these 17 (23.9%) were SA 
patients. Majority were in the age bracket of 60–69 (n = 20) 
and 70-79 (n = 20).
Belief about medicines questionnaire
A total of 14 of the 17 SA patients completed the BMQ. Of 
these 11 patients scored positive on the BMQ-S and 3/14 had 
a negative score. In BMQ-S the 14 SA patients had a mean 
(± SD) necessity score of 21 and a mean (SD) concern score 
Table 1  Results on the belief 
about medicines questionnaire 
specific
A positive differential score indicates that the participants perceive the benefits of their medication to out-
weigh the risks, in contrast negative differential score indicates that participants perceive the risk of taking 
their medication outweigh their benefits
Patient no. Control Intervention Result on BMQ Adherence baseline, 3 months 
6 months
1 BMQ 25/10 Positive 8 8 8
2 BMQ 25/19 Positive 8 8 8
3 BMQ 25/12 Positive 6.75 8 7
4 BMQ 25/12 Positive 7.5 8 7.5
5 BMQ 21/15 Positive 8 8 8
6 BMQ 24/11 Positive 8 8 8
7 BMQ 17/21 Negative 5.75 5.75 5.75
8 BMQ 20/19 Positive 8 8 8
9 BMQ 21/15 Positive 8 8 8
10 BMQ 15/20 Negative 5.75 0.7 0
11 BMQ 19/10 Negative 7 7 8
12 BMQ 19/14 Positive 7 6.75 7
13 BMQ 20/13 Positive 8 8 5.5
14 BMQ 21/16 Positive 8 8 6.75
21/15 Mean score
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of 15 (Table 1). This showed that more patients at 3 months 
believed that the benefit of their medicines outweighed their 
concerns. Patients who had positive BMQ-S scores had a 
score that was positively linked with adherence (Table 1).
Adherence
All 71 patients including 17 SA patients and 54 non-SA 
patients completed the 8-Item Morisky Scale (MMAS-8) 
at baseline. The SA patients’ had a mean (SD) adherence 
MMAS-8 scale of 7.41 from 8 and this decreased with time 
to 7.1 and 6.8 at 3 and 6 months respectively (Fig. 1). A 
similar pattern of adherence to medication was observed in 
the non-SA patients from the pilot study (non-Asian) adher-
ence to medication decreased with time 7.5 at baseline and 
this decreased to 7 and 6.1 at 3 and 6 months respectively. 
Statistical analysis showed that there was no evident differ-
ence in adherence patterns between the SAs’ and the patients 
in the pilot study after an acute myocardial infarction as 
shown in the figure below.
Qualitative interviews
Fourteen interviews were carried out between January 2014 
and April 2014. The interviews lasted around 20 minutes. 
Participants’ ages ranged from 32 to 72 years with 7 patients 
in their 30’s and 40’s. Thirteen were male and one only was 
a female, country of origin of patients included Bangladesh 
(N = 5), Pakistan (N = 3) and India (N = 6). Three main 
themes were derived from the results: perception of patients 
regarding their disease, perception regarding their medica-
tion and factors that influenced adherence to secondary pre-
vention medication, in addition sub-themes emerged from 
the data.
Theme 1 perception of patients regarding their 
disease
South Asian patients’ beliefs and lived early experiences 
about CHD
Beliefs regarding the disease feeling ill versus healthy South 
Asian patients described their experience of a heart attack as 
being intense chest pain accompanied by regular symptoms 
of a heart attack, severe burning pain and vomiting. Few 
patients described it as less intense, one patient believed he 
had a breathing problem and another described it as a vomit-
ing problem.
I had a breathing problem heavily too much and now 
I am walking no breathing problem (male 68 years of 
Indian origin participant no. 1).
Some relatively older patients in this sample believed that 
the disease was acute and after they had a procedure they 
were cured and therefore questioned the necessity of using 
medicine for a long period.
The disease is not serious now, I am not sure whether 
I need medicines and should I continue medicines or 
not? (68 years, male of Indian origin participant no. 1).
When considering the Morisky scale for these patients it was 
observed that they had low scores (e.g. BMQ negative score, 
Morisky scale 5.75 at baseline, 3, 6 months- Fig. 1). Other 
patients found it difficult to accept the disease.
I was healthy and I didn’t take medicine all my life and 
then suddenly you have 6 different medicines a day this 
is a confusion (32 years old male from Bangladesh 
participant no. 3).
Fig. 1  Patterns of adherence. 
*Adherent patients (Morisky 
score moderate 6–8, Morisky 
score high = 8) and patients 
with suboptimal adherence 
(Morisky score < 6). *The pilot 
study included 71 patient 54 
non-South Asian and 17 South 
Asian patients, 14/17 South 
Asian patients’ took part in the 
qualitative interviews
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Causes of the disease
Patients in the interviews reported that the main cause of 
their disease was attributed to genetics and family history 
and that the disease was inevitable and running in families.
My family history my father died only when he was 
51 and my brother when he was only 31 and he died 
he had another heart attack (male from Bangladesh 
participant no. 12).
May be my family, it is running in my family, once you 
have it you have it (male from Bangladesh participant 
no. 3)
Some patients mentioned that the cause could be related to 
their food which was described as containing a lot of rice 
and red meat and also the use of ghee for cooking.
It is our food, we Asians we eat a lot of curry and rice 
and greasy food (male from Bangladesh participant 
no. 14).
The younger patients in this sample linked the importance of 
healthy lifestyle choices for disease prevention.
I was going to the gym and I always look carefully at 
what I eat and I cut down on my alcohol (Patient of 
Pakistani origin age 48 participant no. 4).
I exercise nearly every day, I do this all the time, every 
day I have to go out for a good walk (43 year-old 
patient from Indian origin participant no. 7).
Other reported causes from the interviews included stress 
and a flu after going for Hajj.
I am stressed from my work and it is stress that caused 
my heart attack but God gave me the life (52 years old 
female of Pakistani origin participant no. 2).
Before I was healthy but then I had a flu after back 
from Hajj, this is what it is (72 years old Male Paki-
stani origin participant no. 10).
Fatality: some patients mentioned the idea of the will 
of God and not the individual to determine future 
health.
What can you do I mean if God gave you the life what-
ever he gave, you have to live, it is in God’s hands 
(Female of Pakistani origin participant no. 2).
Worries of having a second heart attack were raised in more 
than half of the patients’ interviews.
Now I worry all the time, it could happen any time 
again (male of Pakistani origin participant no. 10).
Some patients in this sample believed that the medicines 
might be able to prevent recurrence of CHD, these patients 
had positive BMQ-S scores.
Theme 2 perception of patients regarding their 
medicines
South Asians’ beliefs, experiences and behaviours relating 
to medication taking in CHD
Role of medication necessity verses concerns The majority 
of patients perceived the medicines to be very important for 
their current health and only few where not sure. However, 
some patients expressed that the number of tablets to take 
was high and this led to additional concern regarding medi-
cine safety.
I think they are pretty important that is the reason they 
gave them to me but too much medicine, is this good 
for you? (male of Indian origin participant no. 8.)
Knowledge regarding the medicines
Half of the patients in this sample were able to list what 
their medicines were for. On the other hand half reported 
little knowledge, mostly relying on family members or on a 
healthcare professional or simply not interested in knowing.
They are for cholesterol and clotting something like 
that, do not really know (male of Bangladeshi origin 
participant no. 5).
Chemist explained but memory not good (male of 
Bangladeshi origin participant no. 9).
Yes my GP told my son and at the hospital they told 
my son this is for this and this is for that, but they are 
important to take (Female Pakistani origin participant 
no. 2).
Theme 3 factors that influenced adherence 
to secondary prevention medication
Factors derived from the interviews that influenced 
adherence in interviewed South Asian patients
Forgetfulness Several patients had problems with remem-
bering to take their medications. The patients reported that 
this was attributed to being on medication for the first time, 
their age, or trying to fit the medication into a habit as a 
daily routine.
I take the medication all once a day so if I forget I 
forget the whole lot (Bangladeshi patient aged 42 par-
ticipant no. 12).
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These patients were young patients and reported that their 
non-adherence was unintentional. They expressed a need to 
accept the disease and adapt to a new life style and routine 
that would include medication taking. Ways to remember to 
take medicines were reported as use of a pill box, writing on 
the boxes in native language, arranging them in a bag and 
making them accessible around the house.
Family support
Family support varied among the patients, support was 
either offered as help in organizing the medicines, provid-
ing the knowledge about the medicines, helping with healthy 
eating and stress management. The patients’ reported that 
family support they received helped with their adherence 
to the medicines.
My sister and my cousin they are trying to help me, 
my daughter gives me the medicine and I just take so 
I remember (male of Indian origin participant no. 6).
Side effects
The main side effects reported by the patients included mus-
cle pain, coughing, cold extremities, bruising and lethargy. 
The patients who experienced side effects reported in the 
interviews that they continued to take their medicines.
One tablet ramipril tablet I was coughing and the 
coughing comes and goes every time, I told my GP 
and now I am on a different medication and I take 
it every day (male of Pakistani origin participant no. 
participant no. 10).
My feet do feel cold then they do not stay long it is just 
you know, it is not a major thing I still take my medi-
cine (Female of Pakistani origin participant no. 2).
Relying on health care practitioner
More than half of the patients relied on a healthcare practi-
tioner regarding the decision to take medicines.
The doctor said they are important for my body, I do 
not think about it if doctor says I need it then I need 
it that’s it (male of Indian origin participant no. 11).
Living in areas of deprivation
Two patients reported living in areas of deprivation (bad 
accommodation, large families, drugs and depressing envi-
ronments) which affected healthy dietary choices and added 
further stress to their physical and mental health. This was 
accompanied by depression and had a negative effect on 
adherence to medicines after a CHD.
I have been living in this hostel for 4 years and people 
in this place are too many they are always banging 
shouting and screaming, I cook my food and if I leave 
it for 10 min it is gone from the cooker, I need to get 
out of this hole (male of Bangladeshi origin participant 
no. 5) BMQ Negative score, Morisky scale 5.75, 0.7, 
0 at baseline, 3, 6 months).
Cardiac rehabilitation
All the patients had either attended or were committed to 
attending cardiac rehabilitation, except one patient that 
thought that cardiac rehabilitation was further injections 
and procedures.
No I didn’t go to cardiac rehabilitation. If they start 
putting injections again, I do not want to go through 
that again (male of Bangladeshi origin participant no. 
3).
The patients’ who attended cardiac rehabilitation reported 
that it was very useful and helpful.
I went to cardiac rehabilitation and I am thinking right 
now of joining a gym, I have changed the food I eat 
after cardiac rehabilitation (male of Bangladeshi origin 
participant no. 5).
Discussion
Key findings
The results illustrate that there was a belief in the importance 
of the medicines after a coronary event. The patients who 
adhered to the medicines believed that the medicines could 
prevent future events. Older patients perceived the disease to 
be of an acute nature and were unable to recognise unhealthy 
life style as a risk for CHD. In contrast younger patients 
had difficulty in accepting the disease and this affected their 
ability to adapt to a routine for medication taking; but were 
more aware of risk factors for CHD. CHD is perceived as a 
disease of senior citizens, as only 4–10% of all MIs occur 
before age 45 [19]. However, SA patients more often experi-
ence CHD before the age of 40; and in this sample half of 
the patients were in their 30’s and 40’s. Patients reported in 
the interviews that family history and genetics were the main 
cause of their disease, also that the disease was inevitable 
and thus early prevention and further treatment might not 
have a significant role. Moreover, patients expressed strong 
family support with their disease and medication.
This study included a small sample size. Nevertheless a 
similar pattern of adherence to medication was observed in 
the SA patients compared to the non-SA patients (n = 54) 
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from the pilot study. Adherence reduced with time in both 
groups. The SA participants’ in this study expressed the 
importance of attending cardiac rehabilitation and had 
attended or were scheduled to attend. Previous literature 
has shown that low-levels of cardiac rehabilitation participa-
tion among SA and other ethnic minority groups have been 
reported in several English-speaking countries including the 
USA, Canada, the UK and Australia [20]. This has been 
attributed to reasons such as exercise, culture and religion, 
programme access and structure and communication and 
language [21]. In the UK, the key health policy outlining 
the national standard for cardiac rehabilitation, the National 
Service Framework (NSF) for Coronary Heart Disease [22], 
states that services should be accessible and acceptable to 
all the people they serve regardless of their ethnicity. This 
includes services able to meet people’s needs in ways that 
are culturally, religiously and linguistically appropriate [23]. 
Several UK-based community health projects designed to 
improve CHD prevention and rehabilitation among SA indi-
viduals, such as Project Dil in Leicester [24], the BRUM 
study in Birmingham [25] and the Khush Dil project in 
Edinburgh [10], offer encouraging directions for healthcare 
professionals, in the design and delivery of culturally sensi-
tive cardiac rehabilitation services [21].
The findings in this study should be approached with cau-
tion due to the small sample size and the short length of the 
interviews. Nevertheless, this study showed that increased 
belief regarding the necessity of the medicines was associ-
ated with positive adherence scores. This finding is in line 
with other studies with large sample sizes, for example a 
study that involved 1611 coronary heart disease patients 
from 35 practices in Ireland found; that a strong belief in 
the necessity of one’s medication and a lower level of con-
cern about one’s medication were related with higher levels 
of adherence [26].
Studies in patients with chronic diseases have previously 
shown that medication adherence can be improved if patients 
are provided with information regarding the prescribed med-
icines [27]. Factors that influenced adherence in our study 
included: forgetfulness, depression, side effects, living in 
areas of deprivation. These factors fall under the WHO 
framework for medication adherence that lists reasons for 
non-adherence to include younger age, socioeconomic fac-
tors, mental health (depression) and side effects [28] and can 
also be compared to results of a review [6] that concluded 
that medication side-effects, knowledge regarding the medi-
cines, cost, forgetfulness and higher frequency of dosing are 
contributed to non-adherence.
The patients expressed in interviews that they follow doc-
tors’ orders and instructions with the belief that health man-
agement should be left to qualified health professionals. This 
has also been concluded in other studies examining health 
beliefs of UK SAs’ related to chronic diseases [29].
SA population in our study were aware of risk factors 
for CHD, however, the older participants in this sample 
seemed less aware of the general facts about CHD. Previ-
ous published literature has shown that awareness may be 
high in the general population regarding CHD compared to 
other diseases. The UK’s 2007 National Stroke Strategy for 
England (NSSFE) showed that the general population aware-
ness is high for coronary heart disease but lower for stroke 
[30]. A further study in 2010 agreed with the NSSFE view, 
which showed there was more awareness of general facts in 
the population about CHD than stroke [30]. Nevertheless, 
a previous cross-sectional UK study including 334 SA men 
and women aged 16–74 years showed that for both heart 
disease and diabetes, two-thirds of respondents said they did 
not understand enough about the conditions to prevent them 
[31]. In interviews 35% of people said they did not under-
stand the meaning of the term heart disease, 14% could not 
give a single cause, and 17% could not suggest a preventive 
measure. [31].
Limitations
In this study patients unable to understand and communicate 
in English were not included, this was a restriction to under-
standing communication barriers between SA patients and 
health care practitioners and how this could reflect on adher-
ence. Other limitations include imbalanced gender mostly 
male and only one female took part in the interviews, there-
fore the view might not be representative. Furthermore, tel-
ephone interview has drawbacks against face-to-face inter-
view: e.g. not able to build rapport with participants, people 
might be less likely to talk on the phone, which subsequently 
did not generate rich data.
Recommendations for practice and research
Due to the small number of participants in our study a larger 
qualitative study focusing on SA uptake of programmes such 
as cardiac rehabilitation would be of benefit. Emphasis on 
primary prevention in high risk SAs needs to be prioritised, 
this can be achieved by education about the excess risk and 
risk factors and by campaigns targeted and tailored towards 
SA communities living in the UK.
Conclusion
This article sheds light on secondary prevention after a myo-
cardial infarction in SA patients, in regards to behaviour, 
adherence to medicine, living with the disease and cardiac 
rehabilitation. Similar adherence patterns to coronary heart 
disease, secondary prevention medication in SA patients and 
the non-Asian patients included in this sample. However, 
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older SA participants in this study perceived the disease to 
be of an acute nature, in contrast younger patients despite 
being more aware of the facts and risk factors for CHD, 
had difficulty in accepting the disease and this affected their 
ability to adapt to a routine for medication taking. There are 
very few studies focusing on beliefs and adherence patterns 
after coronary heart disease of SAs in the UK and due to the 
large SA population in the UK, larger studies of this nature 
are imperative.
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